What's the Latest in the Pipeline for MS Drugs that Might Help?
"Whether you’ve just been diagnosed with multiple sclerosis or you’ve been dealing with your symptoms for years, it’s in your best interest to keep on top of the latest advances in medications. The good news is there are plenty of drugs being tested, and hopefully many will get through the regulatory pipeline to help patients cope with their MS. . ."
...
moreOcrelizumab (OCREVUS™), an anti-B cell therapy has been approved by the FDA as of March 28th 2017, for the treatment of Relapsing-remitting multiple sclerosis (RRMS) and primary progressive multiple sclerosis (PPMS). This treatment is highly effective for RRMS, based on the data from the Phase III clinical studies. It is also the first drug approved for use in PPMS. At IMSMP/TISCH we have used Rituximab, a similar anti-B cell treatment, for the past 16 years with great success. It is because...
moreWe are looking for patient stories to post on social media throughout the month of March and all year round! Please share with us what keeps you motivated, how you achieve your goals and triumphs along the way. The IMSMP is inspired every day by our patients. Help us share that inspiration! To be a part of these special posts, please email: plevin@imsmp.org...
moreCongratulations to Dr. Saud A. Sadiq, Dr. Andrew Sylvester and Dr. Armistead D. Williams who have all been named a 2017 Top Doctor in the field of Neurology for the New York Metro Area by Castle Connolly. In addition, Dr. Sadiq has been named a 2017 America's Top Doctor in the field of Neurology by Castle Connolly.
The mission of Castle Connolly Medical Ltd. is to help consumers find the best healthcare. To this end, they publish a variety of books including the "Top Doctors" series,...
moreGreat article and great way to start the new year. Time for a change in Connecticut for the access symbol. Read the full article here: http://www.newmobility.com/2017/01/connecticut-updates-access-symbol/
Learn more about Phase II of the Tisch MSRCNY Stem Cell Trial for MS and how it differs from HSCT. CLICK HERE to watch this informative interview!
The IMSMP will be closed on Friday, December 30th, 2016 and Monday, January 2nd, 2017. A neurologist will be available for any MS related emergencies by calling (212) 265-8070. The Center will re-open on Tuesday, January 3rd, 2017. We wish everyone a safe holiday weekend and a wonderful year to come, filled with health and happiness!
Tisch MSRCNY is preparing for construction to commence January 2017 of a state-of-the-art stem cell facility on our 3rd floor. This could not have been done without the generosity of our supporters. The build-out of our new research laboratory enables Phase II of the Tisch MSRCNY FDA-approved stem cell clinical trial to move forward.
We are NOT enrolling patients in the study at this time. We anticipate the trial to commence in June of 2017. Please Click Here to check the ...
moreDawn Goodell shares her inspirational and informative story on prevention.com this month. From diagnosis and how life has changed, Dawn details what life has been like and what she hopes for the future, in this great feature article! Click Here for Dawn's Story
The IMSMP will close at 2:00pm on Wednesday, November 23rd and remain closed through the weekend for Thanksgiving. An IMSMP neurologist will be available for any emergencies by calling (212) 265-8070. We wish you and your family a happy & healthy Thanksgiving weekend! The Center will re-open on Monday, November 28th, 2016.
Because you deserve only the best in MS healthcare. Experience the difference.
Join our mailing list today! Receive the latest information and updates happening in MS research, treatment and care including, Healing MS, the IMSMP newsletter.
* We don’t share your information with anyone.
